TARA logo

Protara Therapeutics (TARA)

Profile

Full Name

Protara Therapeutics, Inc.

Ticker Symbol

TARA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 22, 2014

Indexes

Not included

Website

http://www.protaratx.com

Employees

28

Key Details

Price

$4.15(-0.48%)

Market cap

$152.59M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$2.17(+39.22% YoY)

PE ratio

-

Next earnings date

May 2, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$4.15
TARA price is $4.15

30-Day Relative Volume

1.59
TARA 30-day relative volume is 1.59

Price Performance

Price Today change

-0.48%
TARA price is down -0.48% today

Price YTD change

-21.4%
TARA price is down -21.4% since January 1st

Price 1-year change

+45.61%
TARA price is up +45.61% year-on-year

Price 3-year change

-9.39%
TARA price is down -9.39% over the past 3 years

Price Range

Price All-time high

$800.00
TARA price is currently -99.48% below its historical high of $800.00

Price 3-year low

$1.04
TARA price is currently +299.04% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$152.59M
TARA market capitalization is $152.59 million

Market cap 3-year change

+196.09%
TARA market capitalization is up +196.09% over the past 3 years

Market cap All-time high

$354.68M
TARA market capitalization is currently -56.98% below its historical high of $354.68 million

Market cap sector rank

53.7%
TARA market capitalization is higher than 53.7% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+78.67%
TARA shares outstanding is up +78.67% year-on-year

Shares Outstanding 3-Year Change

+226.77%
TARA shares outstanding is up +226.77% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.07
TARA beta is 1.07

200-day SMA

$3.26
TARA price is currently +27.24% above its 200-day simple moving average

50-day SMA

$4.12
TARA price is currently +0.61% above its 50-day simple moving average

RSI

50.79
TARA 14-day relative strength index is 50.79

Volume

1.59
TARA 30-day relative volume is 1.59

ATR

$0.31
TARA average true range is $0.31

10-day Historical Volatility

92.87%
TARA 10-day historical volatility is 92.87%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
TARA annual revenue value is unknown

Revenue Analysts estimate

-
TARA annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
TARA annual revenue 1-year change is unknown

Revenue Sector rank

-
TARA annual revenue is unknown

EPS

EPS

-$2.17
TARA annual earnings per share is -$2.17

EPS Analysts estimate

-$1.90
TARA annual earnings per share is currently +14.06% higher than the consensus analysts' forecast

EPS 1-year change

+39.22%
TARA annual earnings per share is up +39.22% year-on-year

EPS Sector rank

36.87%
TARA annual earnings per share is higher than 36.87% of companies in Healthcare sector

Profit

Gross profit

-
TARA annual gross profit value is unknown

Gross margin

-
TARA annual gross profit margin value is unknown

Operating profit

-$49.15M
TARA annual operating income is -$49.15 million

Operating margin

-
TARA annual operating profit margin value is unknown

Net income

-$44.60M
TARA annual net profit is -$44.60 million

Net margin

-
TARA annual net profit margin value is unknown

Expenses

Total expenses

$49.15M
TARA annual total expenses is $49.15 million

Operating expenses

$49.15M
TARA annual total operating expenses is $49.15 million

Cost of goods sold

-
TARA annual cost of goods sold value is unknown

Selling, general & administrative expenses

$17.45M
TARA annual SGA is $17.45 million

Depreciation and amortization

$332.00K
TARA annual depreciation & amortization is $332.00 thousand

Interest expense

-
TARA annual interest expense value is unknown

Income tax

-
TARA annual income tax value is unknown

EBIT & EBITDA

EBIT

-$49.15M
TARA annual earnings before interest & taxes is -$49.15 million

EBITDA

-$49.15M
TARA annual EBITDA is -$49.15 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$181.45M
TARA annual total assets is $181.45 million

Non current assets

$9.30M
TARA annual long term assets is $9.30 million

Current assets

$172.16M
TARA annual total current assets is $172.16 million

Cash and cash equivalents

$162.80M
TARA annual cash & cash equivalents is $162.80 million

Accounts receivable

-
TARA annual accounts receivable value is unknown

Inventory

-
TARA annual inventory value is unknown

Liabilities

Total liabilities

$14.32M
TARA annual total liabilities is $14.32 million

Long term liabilities

$3.36M
TARA annual total long term liabilities is $3.36 million

Current liabilities

$10.96M
TARA annual total current liabilities is $10.96 million

Accounts payable

$4.43M
TARA annual accounts payable is $4.43 million

Debt

Total debt

$4.48M
TARA annual total debt is $4.48 million

Total debt 1-year change

-18%
TARA annual total debt is down -18% year-on-year

Long term debt

$3.36M
TARA annual long term debt is $3.36 million

Short term debt

$1.12M
TARA annual short term debt is $1.12 million

Equity & Capital

Shareholders equity

$167.13M
TARA annual stockholders equity is $167.13 million

Book value

$167.13M
TARA annual book value is $167.13 million

Retained earnings

-$244.98M
TARA annual retained earnings is -$244.98 million

Working capital

$161.19M
TARA annual working capital is $161.19 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$35.81M
TARA annual cash flow from operations is -$35.81 million

Cash from operations 1-year change

+4.66%
TARA annual cash flow from operations is up +4.66% year-on-year

Cash from investing

$19.16M
TARA annual cash flow from investing activities is $19.16 million

Cash from investing 1-year change

-63.93%
TARA annual cash flow from investing activities is down -63.93% year-on-year

Cash from financing

$139.87M
TARA annual cash flow from financing activities is $139.87 million

Cash from financing 1-year change

+153797.8%
TARA annual cash flow from financing activities is up +153797.8% year-on-year

CAPEX

CAPEX

-
TARA annual capital expenditures value is unknown

CAPEX 1-year change

-
TARA annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$35.87M
TARA annual free cash flow is -$35.87 million

Free cash flow 1-year change

+4.6%
TARA annual free cash flow is up +4.6% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
TARA annual gross profit margin value is unknown

Operating margin

-
TARA annual operating profit margin value is unknown

Net margin

-
TARA annual net profit margin value is unknown

ROA & ROE

ROA

-24.58%
TARA annual return on assets is -24.58%

ROE

-26.68%
TARA annual return on equity is -26.68%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
TARA price to earnings ratio value is unknown

PE ratio Sector rank

-
TARA price to earnings ratio is unknown

PB Ratio

PB ratio

0.91
TARA price to book ratio is 0.91

PB ratio Sector rank

42.55%
TARA price to book ratio is higher than 42.55% of companies in Healthcare sector

PS Ratio

PS ratio

-
TARA price to sales ratio value is unknown

PS ratio Sector rank

-
TARA price to sales ratio is unknown

Enterprise value

Enterprise value

-$5.73M
TARA enterprise value is -$5.73 million

Enterprise value Sector rank

6.29%
TARA enterprise value is higher than 6.29% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.12
TARA EV/EBITDA is 0.12

EV/EBITDA Sector rank

67.97%
TARA EV/EBITDA is higher than 67.97% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

15.71
TARA annual current ratio is 15.71

Quick ratio

-
TARA annual quick ratio value is unknown

Leverage

Debt to equity

0.03
TARA annual debt to equity ratio is 0.03

Interest coverage ratio

-
TARA annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
TARA piotroski f-score value is unknown

Altman Z-Score

-
TARA altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 14, 25 Cantor Fitzgerald
Overweight
Mar 11, 25 LifeSci Capital
Outperform
Mar 6, 25 HC Wainwright & Co.
Buy
Dec 6, 24 HC Wainwright & Co.
Buy
Dec 6, 24 Guggenheim
Buy
Nov 14, 24 HC Wainwright & Co.
Buy
Aug 12, 24 Oppenheimer
Outperform
Aug 8, 24 HC Wainwright & Co.
Buy
May 6, 24 HC Wainwright & Co.
Buy
Apr 22, 24 Oppenheimer
Outperform

Institutional Ownership

Similar stocks

OPRX logo
OptimizeRx (OPRX)
MYO logo
Myomo (MYO)
ARAY logo
Accuray Incorporated (ARAY)
STXS logo
Stereotaxis (STXS)
CATX logo
Perspective Therapeutics (CATX)
American Oncology Network (AONC)
ACIU logo
AC Immune SA (ACIU)
Actuate Therapeutics (ACTU)
DMAC logo
DiaMedica Therapeutics (DMAC)
  • What is the ticker symbol for Protara Therapeutics?
  • Does Protara Therapeutics pay dividends?
  • What sector is Protara Therapeutics in?
  • What industry is Protara Therapeutics in?
  • What country is Protara Therapeutics based in?
  • When did Protara Therapeutics go public?
  • Is Protara Therapeutics in the S&P 500?
  • Is Protara Therapeutics in the NASDAQ 100?
  • Is Protara Therapeutics in the Dow Jones?
  • When was Protara Therapeutics's last earnings report?
  • When does Protara Therapeutics report earnings?
  • Should I buy Protara Therapeutics stock now?

What is the ticker symbol for Protara Therapeutics?

The ticker symbol for Protara Therapeutics is NASDAQ:TARA

Does Protara Therapeutics pay dividends?

No, Protara Therapeutics does not pay dividends

What sector is Protara Therapeutics in?

Protara Therapeutics is in the Healthcare sector

What industry is Protara Therapeutics in?

Protara Therapeutics is in the Biotechnology industry

What country is Protara Therapeutics based in?

Protara Therapeutics is headquartered in United States

When did Protara Therapeutics go public?

Protara Therapeutics's initial public offering (IPO) was on October 22, 2014

Is Protara Therapeutics in the S&P 500?

No, Protara Therapeutics is not included in the S&P 500 index

Is Protara Therapeutics in the NASDAQ 100?

No, Protara Therapeutics is not included in the NASDAQ 100 index

Is Protara Therapeutics in the Dow Jones?

No, Protara Therapeutics is not included in the Dow Jones index

When was Protara Therapeutics's last earnings report?

Protara Therapeutics's most recent earnings report was on Mar 5, 2025

When does Protara Therapeutics report earnings?

The next expected earnings date for Protara Therapeutics is May 2, 2025

Should I buy Protara Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page